Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP945921.RAN7sSmb-IktH6VE5m9R3IeFadOmLH_pEdiWpI2_SYJs8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP945921.RAN7sSmb-IktH6VE5m9R3IeFadOmLH_pEdiWpI2_SYJs8130_assertion type Assertion NP945921.RAN7sSmb-IktH6VE5m9R3IeFadOmLH_pEdiWpI2_SYJs8130_head.
- NP945921.RAN7sSmb-IktH6VE5m9R3IeFadOmLH_pEdiWpI2_SYJs8130_assertion description "[The development of genetically engineered mice with ablation of NF1, NF2, SMARCB1/INI1 or PRKAR1A has confirmed the key role these genes play in peripheral nerve sheath tumorigenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP945921.RAN7sSmb-IktH6VE5m9R3IeFadOmLH_pEdiWpI2_SYJs8130_provenance.
- NP945921.RAN7sSmb-IktH6VE5m9R3IeFadOmLH_pEdiWpI2_SYJs8130_assertion evidence source_evidence_literature NP945921.RAN7sSmb-IktH6VE5m9R3IeFadOmLH_pEdiWpI2_SYJs8130_provenance.
- NP945921.RAN7sSmb-IktH6VE5m9R3IeFadOmLH_pEdiWpI2_SYJs8130_assertion SIO_000772 22160322 NP945921.RAN7sSmb-IktH6VE5m9R3IeFadOmLH_pEdiWpI2_SYJs8130_provenance.
- NP945921.RAN7sSmb-IktH6VE5m9R3IeFadOmLH_pEdiWpI2_SYJs8130_assertion wasDerivedFrom befree-2016 NP945921.RAN7sSmb-IktH6VE5m9R3IeFadOmLH_pEdiWpI2_SYJs8130_provenance.
- NP945921.RAN7sSmb-IktH6VE5m9R3IeFadOmLH_pEdiWpI2_SYJs8130_assertion wasGeneratedBy ECO_0000203 NP945921.RAN7sSmb-IktH6VE5m9R3IeFadOmLH_pEdiWpI2_SYJs8130_provenance.